{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:17:29Z","timestamp":1789773449541,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["PhD fellowship strategic basic research (FWO-SB)"],"award-info":[{"award-number":["PhD fellowship strategic basic research (FWO-SB)"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["senior clinical research fellowship"],"award-info":[{"award-number":["senior clinical research fellowship"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite increasing use of continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII, insulin pumps) in type 1 diabetes (T1D) in pregnancy, achieving recommended pregnancy glycaemic targets (3.5\u20137.8 mmol\/L or 63\u2013140\u00a0mg\/dL) remains challenging. Consequently, the risk of adverse pregnancy outcomes remains high. Outside pregnancy, hybrid closed-loop (HCL) insulin delivery systems have led to a paradigm shift in the management of T1D, with 12% higher time in glucose target range (TIR) compared to conventional CSII. However, most commercially available HCL systems are currently not approved for use in pregnancy. This study aims to evaluate the efficacy, safety and cost-effectiveness of the MiniMed\u2122 780G HCL system (Medtronic) in T1D in pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this international, open-label, randomized controlled trial (RCT), we will compare the MiniMed\u2122 780G HCL system to standard of care (SoC) in T1D in pregnancy. Women aged 18\u201345 years with T1D diagnosis of at least one year, HbA1c\u2009\u2264\u200986 mmol\/mol (\u2264\u200910%), and confirmed singleton pregnancy up to 11 weeks 6 days will be eligible. After providing written informed consent, all participants will wear a similar CGM system (Guardian\u2122 3 or Guardian\u2122 4 CGM) during a 10-day run-in phase. After the run-in phase, participants will be randomised 1:1 to 780G HCL (intervention) or SoC [control, continuation of current T1D treatment with multiple daily injections (MDI) or CSII and any type of CGM] stratified according to centre, baseline HbA1c (&lt;\u200953 vs.\u2009\u2265\u200953 mmol\/mol or &lt;\u20097 vs.\u2009\u2265\u20097%), and method of insulin delivery (MDI or CSII). The primary outcome will be the time spent within the pregnancy glucose target range, as measured by the CGM at four time points in pregnancy: 14\u201317, 20\u201323, 26\u201329, and 33\u201336 weeks. Prespecified secondary outcomes will be overnight TIR, time below range (TBR: &lt;3.5 mmol\/L or &lt;\u200963\u00a0mg\/dL), and overnight TBR. Other outcomes will be exploratory. The planned sample size is 92 participants. The study will end after postpartum discharge from hospital. Analyses will be performed according to intention-to-treat as well as per protocol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This large RCT will evaluate a widely used commercially available HCL system in T1D in pregnancy. Recruitment began in January 2021 and was completed in October 2022. Study completion is expected in May 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov: NCT04520971. Registration date: August 20, 2020.\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04520971\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04520971<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-023-05481-0","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T16:41:51Z","timestamp":1679848911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial \u2013 study protocol"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3557-0022","authenticated-orcid":false,"given":"Kaat","family":"Beunen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Van Wilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Ballaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Vanhaverbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youri","family":"Taes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier-Philippe","family":"Aers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Nobels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke","family":"Marlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke","family":"Cuypers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Preumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Siegelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Painter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annouschka","family":"Laenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Gillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3325-0263","authenticated-orcid":false,"given":"Katrien","family":"Benhalima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"issue":"7445","key":"5481_CR1","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1136\/bmj.38043.583160.EE","volume":"328","author":"IM Evers","year":"2004","unstructured":"Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004;328(7445):915.","journal-title":"BMJ"},{"issue":"11","key":"5481_CR2","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.2337\/dc09-0656","volume":"32","author":"M Persson","year":"2009","unstructured":"Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care. 2009;32(11):2005\u20139.","journal-title":"Diabetes Care"},{"issue":"6","key":"5481_CR3","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.2337\/dc13-2717","volume":"37","author":"DS Feig","year":"2014","unstructured":"Feig DS, Hwee J, Shah BR, Booth GL, Bierman AS, Lipscombe LL. Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996\u20132010. Diabetes Care. 2014;37(6):1590\u20136.","journal-title":"Diabetes Care"},{"issue":"7560","key":"5481_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/bmj.38856.692986.AE","volume":"333","author":"MC Macintosh","year":"2006","unstructured":"Macintosh MC, Fleming KM, Bailey JA, Doyle P, Modder J, Acolet D, et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ. 2006;333(7560):177.","journal-title":"BMJ"},{"issue":"8","key":"5481_CR5","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical targets for continuous glucose Monitoring Data Interpretation: recommendations from the International Consensus on Time in Range. Diabetes Care. 2019;42(8):1593\u2013603.","journal-title":"Diabetes Care"},{"issue":"3","key":"5481_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s00125-009-1633-z","volume":"53","author":"A Garc\u00eda-Patterson","year":"2010","unstructured":"Garc\u00eda-Patterson A, Gich I, Amini SB, Catalano PM, de Leiva A, Corcoy R. Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction. Diabetologia. 2010;53(3):446\u201351.","journal-title":"Diabetologia"},{"issue":"2","key":"5481_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s00125-011-2363-6","volume":"55","author":"HR Murphy","year":"2012","unstructured":"Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, et al. Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy. Diabetologia. 2012;55(2):282\u201393.","journal-title":"Diabetologia"},{"issue":"10110","key":"5481_CR8","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","volume":"390","author":"DS Feig","year":"2017","unstructured":"Feig DS, Donovan LE, Corcoy R, Murphy KE, Amiel SA, Hunt KF, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017;390(10110):2347\u201359.","journal-title":"Lancet"},{"issue":"7","key":"5481_CR9","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00125-019-4850-0","volume":"62","author":"K Kristensen","year":"2019","unstructured":"Kristensen K, \u00d6gge LE, Sengpiel V, Kj\u00f6lhede K, Dotevall A, Elfvin A, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies. Diabetologia. 2019;62(7):1143\u201353.","journal-title":"Diabetologia"},{"issue":"5","key":"5481_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1089\/dia.2016.0412","volume":"19","author":"SK Abell","year":"2017","unstructured":"Abell SK, Suen M, Pease A, Boyle JA, Soldatos G, Regan J, et al. Pregnancy outcomes and insulin requirements in women with type 1 diabetes treated with continuous Subcutaneous insulin infusion and multiple daily injections: Cohort Study. Diabetes Technol Ther. 2017;19(5):280\u20137.","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"5481_CR11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00125-014-3163-6","volume":"57","author":"MM Kallas-Koeman","year":"2014","unstructured":"Kallas-Koeman MM, Kong JM, Klinke JA, Butalia S, Lodha AK, Lim KI, et al. Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes. Diabetologia. 2014;57(4):681\u20139.","journal-title":"Diabetologia"},{"issue":"5","key":"5481_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1530\/EJE-17-0804","volume":"178","author":"PM Rys","year":"2018","unstructured":"Rys PM, Ludwig-Slomczynska AH, Cyganek K, Malecki MT. Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies. Eur J Endocrinol. 2018;178(5):545\u201363.","journal-title":"Eur J Endocrinol"},{"key":"5481_CR13","doi-asserted-by":"publisher","first-page":"108628","DOI":"10.1016\/j.diabres.2020.108628","volume":"172","author":"M \u017burawska-Kli\u015b","year":"2021","unstructured":"\u017burawska-Kli\u015b M, Kosi\u0144ski M, Kuchnicka A, Rurka M, Ha\u0142ucha J, W\u00f3jcik M, et al. Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes - significance of pregnancy planning and prepregnancy HbA1c. Diabetes Res Clin Pract. 2021;172:108628.","journal-title":"Diabetes Res Clin Pract"},{"key":"5481_CR14","doi-asserted-by":"crossref","unstructured":"Cummins E, Royle P, Snaith A, Greene A, Robertson L, McIntyre L et al. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Health Technol Assess. 2010;14(11):iii-iv, xi-xvi, 1-181.","DOI":"10.3310\/hta14110"},{"issue":"7","key":"5481_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S2213-8587(17)30167-5","volume":"5","author":"A Weisman","year":"2017","unstructured":"Weisman A, Bai JW, Cardinez M, Kramer CK, Perkins BA. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol. 2017;5(7):501\u201312.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"5481_CR16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/dom.14273","volume":"23","author":"L Leelarathna","year":"2021","unstructured":"Leelarathna L, Choudhary P, Wilmot EG, Lumb A, Street T, Kar P, et al. Hybrid closed-loop therapy: where are we in 2021? Diabetes Obes Metab. 2021;23(3):655\u201360.","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"5481_CR17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00125-021-05391-w","volume":"64","author":"CK Boughton","year":"2021","unstructured":"Boughton CK, Hovorka R. New closed-loop insulin systems. Diabetologia. 2021;64(5):1007\u201315.","journal-title":"Diabetologia"},{"issue":"2","key":"5481_CR18","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2337\/dc10-1796","volume":"34","author":"HR Murphy","year":"2011","unstructured":"Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, et al. Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes. Diabetes Care. 2011;34(2):406\u201311.","journal-title":"Diabetes Care"},{"issue":"12","key":"5481_CR19","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.2337\/dc11-1430","volume":"34","author":"HR Murphy","year":"2011","unstructured":"Murphy HR, Kumareswaran K, Elleri D, Allen JM, Caldwell K, Biagioni M, et al. Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series. Diabetes Care. 2011;34(12):2527\u20139.","journal-title":"Diabetes Care"},{"issue":"7","key":"5481_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1602494","volume":"375","author":"ZA Stewart","year":"2016","unstructured":"Stewart ZA, Wilinska ME, Hartnell S, Temple RC, Rayman G, Stanley KP, et al. Closed-Loop insulin delivery during pregnancy in women with type 1 diabetes. N Engl J Med. 2016;375(7):644\u201354.","journal-title":"N Engl J Med"},{"issue":"7","key":"5481_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1089\/dia.2018.0060","volume":"20","author":"ZA Stewart","year":"2018","unstructured":"Stewart ZA, Yamamoto JM, Wilinska ME, Hartnell S, Farrington C, Hovorka R, et al. Adaptability of closed Loop during Labor, Delivery, and Postpartum: a secondary analysis of data from two randomized crossover trials in type 1 diabetes pregnancy. Diabetes Technol Ther. 2018;20(7):501\u20135.","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"5481_CR22","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2337\/dc17-2534","volume":"41","author":"ZA Stewart","year":"2018","unstructured":"Stewart ZA, Wilinska ME, Hartnell S, O\u2019Neil LK, Rayman G, Scott EM, et al. Day-and-night Closed-Loop insulin delivery in a Broad Population of pregnant women with type 1 diabetes: a randomized controlled crossover trial. Diabetes Care. 2018;41(7):1391\u20139.","journal-title":"Diabetes Care"},{"key":"5481_CR23","doi-asserted-by":"publisher","first-page":"768639","DOI":"10.3389\/fendo.2021.768639","volume":"12","author":"B Ozaslan","year":"2021","unstructured":"Ozaslan B, Deshpande S, Doyle FJ, Dassau E. Zone-MPC Automated insulin delivery algorithm tuned for pregnancy complicated by type 1 diabetes. Front Endocrinol (Lausanne). 2021;12:768639.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"5481_CR24","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1111\/1471-0528.16825","volume":"128","author":"O Kgosidialwa","year":"2021","unstructured":"Kgosidialwa O, Bogdanet D, Egan AM, O\u2019Shea PM, Newman C, Griffin TP, et al. A core outcome set for the treatment of pregnant women with pregestational diabetes: an international consensus study. BJOG. 2021;128(11):1855\u201368.","journal-title":"BJOG"},{"issue":"3","key":"5481_CR25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2337\/dc18-1444","volume":"42","author":"RW Beck","year":"2019","unstructured":"Beck RW, Bergenstal RM, Riddlesworth TD, Kollman C, Li Z, Brown AS, et al. Validation of Time in Range as an Outcome measure for diabetes clinical trials. Diabetes Care. 2019;42(3):400\u20135.","journal-title":"Diabetes Care"},{"issue":"11","key":"5481_CR26","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.2337\/diacare.20.11.1655","volume":"20","author":"BP Kovatchev","year":"1997","unstructured":"Kovatchev BP, Cox DJ, Gonder-Frederick LA, Clarke W. Symmetrization of the blood glucose measurement scale and its applications. Diabetes Care. 1997;20(11):1655\u20138.","journal-title":"Diabetes Care"},{"issue":"2","key":"5481_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2337\/diacare.10.2.225","volume":"10","author":"FJ Service","year":"1987","unstructured":"Service FJ, O\u2019Brien PC, Rizza RA. Measurements of glucose control. Diabetes Care. 1987;10(2):225\u201337.","journal-title":"Diabetes Care"},{"key":"5481_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/1471-2393-14-226","volume":"14","author":"K Benhalima","year":"2014","unstructured":"Benhalima K, Van Crombrugge P, Verhaeghe J, Vandeginste S, Verlaenen H, Vercammen C, et al. The belgian diabetes in pregnancy study (BEDIP-N), a multi-centric prospective cohort study on screening for diabetes in pregnancy and gestational diabetes: methodology and design. BMC Pregnancy Childbirth. 2014;14:226.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"5481_CR29","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2337\/dc10-1343","volume":"34","author":"LA Gonder-Frederick","year":"2011","unstructured":"Gonder-Frederick LA, Schmidt KM, Vajda KA, Greear ML, Singh H, Shepard JA, et al. Psychometric properties of the hypoglycemia fear survey-ii for adults with type 1 diabetes. Diabetes Care. 2011;34(4):801\u20136.","journal-title":"Diabetes Care"},{"key":"5481_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1477-7525-7-40","volume":"7","author":"S Petrou","year":"2009","unstructured":"Petrou S, Morrell J, Spiby H. Assessing the empirical validity of alternative multi-attribute utility measures in the maternity context. Health Qual Life Outcomes. 2009;7:40.","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"5481_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11136-011-9940-5","volume":"21","author":"MG Dalfr\u00e0","year":"2012","unstructured":"Dalfr\u00e0 MG, Nicolucci A, Bisson T, Bonsembiante B, Lapolla A, Quality of Life Italian Study Group. Quality of life in pregnancy and post-partum: a study in diabetic patients. Qual Life Res. 2012;21(2):291\u20138.","journal-title":"Qual Life Res"},{"issue":"1","key":"5481_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00125-009-1559-5","volume":"53","author":"BE McGuire","year":"2010","unstructured":"McGuire BE, Morrison TG, Hermanns N, Skovlund S, Eldrup E, Gagliardino J, et al. Short-form measures of diabetes-related emotional distress: the Problem Areas in Diabetes Scale (PAID)-5 and PAID-1. Diabetologia. 2010;53(1):66\u20139.","journal-title":"Diabetologia"},{"issue":"S1","key":"5481_CR33","first-page":"239","volume":"67","author":"C Matthys","year":"2015","unstructured":"Matthys C, Meulemans A, Van Der Schueren B. Development and validation of general FFQ for use in clinical practice. Annals of Nutrition and Metabolism. 2015;67(S1):239\u20139.","journal-title":"Annals of Nutrition and Metabolism"},{"key":"5481_CR34","unstructured":"Bradley C. The diabetes treatment satisfaction questionnaire. DTSQ. ed. Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice. Abingdon: Harwood Academic Publishers; 1994. p. 111 \u2013 32."},{"issue":"3","key":"5481_CR35","doi-asserted-by":"publisher","first-page":"530","DOI":"10.2337\/diacare.22.3.530","volume":"22","author":"C Bradley","year":"1999","unstructured":"Bradley C. Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur. Diabetes Care. 1999;22(3):530\u20132.","journal-title":"Diabetes Care"},{"issue":"7","key":"5481_CR36","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2337\/diacare.17.7.697","volume":"17","author":"AE Gold","year":"1994","unstructured":"Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17(7):697\u2013703.","journal-title":"Diabetes Care"},{"key":"5481_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2143\/TVG.56.1.5000625","volume":"56","author":"H Devlieger","year":"2000","unstructured":"Devlieger H, Martens G, Bekaert A, Eeckels R. Standaarden van geboortegewicht-voor-zwangerschapsduur voor de vlaamse boreling. Tijdschrift voor geneeskunde. 2000;56:1\u201314.","journal-title":"Tijdschrift voor geneeskunde"},{"issue":"2","key":"5481_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jval.2015.02.001","volume":"18","author":"SD Ramsey","year":"2015","unstructured":"Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, et al. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. Value Health. 2015;18(2):161\u201372.","journal-title":"Value Health"},{"issue":"7495","key":"5481_CR39","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1136\/bmj.330.7495.843","volume":"330","author":"DG Altman","year":"2005","unstructured":"Altman DG, Bland JM. Treatment allocation by minimisation. BMJ. 2005;330(7495):843.","journal-title":"BMJ"},{"issue":"Suppl 1","key":"5481_CR40","first-page":"232","volume":"45","author":"B Draznin","year":"2022","unstructured":"Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, et al. 15. Management of diabetes in pregnancy: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):232\u2013S43.","journal-title":"Diabetes Care"},{"issue":"19","key":"5481_CR41","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","volume":"358","author":"BE Metzger","year":"2008","unstructured":"Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991\u20132002.","journal-title":"N Engl J Med"},{"issue":"2","key":"5481_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2337\/db08-1112","volume":"58","author":"HAPO Study Cooperative Research Group","year":"2009","unstructured":"HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome (HAPO) study: associations with neonatal anthropometrics. Diabetes. 2009;58(2):453\u20139.","journal-title":"Diabetes"},{"issue":"4","key":"5481_CR43","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/0002-9378(95)91348-3","volume":"173","author":"PM Catalano","year":"1995","unstructured":"Catalano PM, Thomas AJ, Avallone DA, Amini SB. Anthropometric estimation of neonatal body composition. Am J Obstet Gynecol. 1995;173(4):1176\u201381.","journal-title":"Am J Obstet Gynecol"},{"key":"5481_CR44","doi-asserted-by":"crossref","unstructured":"Diggle HL. Analysis of Longitudinal Data. Oxford University Press; 2002.","DOI":"10.1093\/oso\/9780198524847.001.0001"},{"issue":"23","key":"5481_CR45","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1002\/sim.1585","volume":"22","author":"M Kieser","year":"2003","unstructured":"Kieser M, Friede T. Simple procedures for blinded sample size adjustment that do not affect the type I error rate. Stat Med. 2003;22(23):3571\u201381.","journal-title":"Stat Med"},{"key":"5481_CR46","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/biomet\/63.3.581","volume":"63","author":"DB Rubin","year":"1976","unstructured":"Rubin DB. Inference and Missing Data. Biometrika. 1976;63:581\u201392.","journal-title":"Biometrika"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-05481-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-023-05481-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-05481-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T11:55:54Z","timestamp":1702122954000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-023-05481-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5481"],"URL":"https:\/\/doi.org\/10.1186\/s12884-023-05481-0","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"assertion":[{"value":"17 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was reviewed by the Medical Ethics Review Committees of all participating centers as well as the national competent authorities and approved by the Ethics Committee Research UZ \/ KU Leuven (Belgian registration number: B3222020000272; Dutch registration number NL78535.000.21). Written informed consent will be obtained from each participant before performing any study-related activities.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"180"}}